(Q44980682)

7 December 2017

title

Modulation of HIV peptide antigen specific cellular immune response by synthetic α- and β-defensin peptides (English)

1 reference

7 December 2017

1

Teena Mohan

1 reference

7 December 2017

Chandresh Sharma

2

1 reference

7 December 2017

Ajaz A Bhat

series ordinal

3

1 reference

7 December 2017

D N Rao

series ordinal

4

1 reference

7 December 2017

language of work or name

English

0 references

publication date

4 February 2013

1 reference

7 December 2017

1 reference

7 December 2017

volume

31

1 reference

7 December 2017

issue

13

1 reference

7 December 2017

page(s)

1707-1716

1 reference

Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

HIV type 1 fails to trigger innate immune factor synthesis in differentiated oral epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Purification of a modified form of bovine antithrombin III as an HIV-1 CD8+ T-cell antiviral factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

CD8+ T cell mediated noncytolytic inhibition of human immunodeficiency virus type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Mammalian defensins in immunity: more than just microbicidal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Bioactive fragment of human IL-1beta [163-171] modulates the immune response to synthetic peptides of HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Reassessment of Ellman's reagent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Preparation of microspheres by the solvent evaporation technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Measurement of protein using bicinchoninic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Epithelial antibiotic induced in states of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Epstein-Barr nuclear antigen 1-specific CD4(+) Th1 cells kill Burkitt's lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

Mechanisms for induction of acquired host immunity by neutrophil peptide defensins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.041

10.1016/J.VACCINE.2013.01.041

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference